Does insurance cover Wegovy?

It depends

Wegovy is FDA-approved specifically for chronic weight management, but health plan coverage for weight-loss drugs is inconsistent — many plans exclude them entirely while a growing number cover them with prior authorization and BMI-based criteria.

Covered when The employer or marketplace plan specifically includes a weight-management drug benefit and prior authorization criteria (BMI, comorbidity) are met.
Not when The plan carries a blanket exclusion for weight-loss medications, which remains common.
Not when A prior-authorization renewal is denied because demonstrated weight-loss progress didn't meet the plan's threshold, or the employer drops the benefit at the next plan year.

Verified 2026-10-13Reviewed by Tom Kazarian, former VP at eHealth5 primary sourcesHow verdicts are made

What flips the answer

Covered when
The employer or marketplace plan specifically includes a weight-management drug benefit and prior authorization criteria (BMI, comorbidity) are met.
Not covered when
The plan carries a blanket exclusion for weight-loss medications, which remains common.
Not covered when
A prior-authorization renewal is denied because demonstrated weight-loss progress didn't meet the plan's threshold, or the employer drops the benefit at the next plan year.

Key facts

Verdict: It depends
Applies to: Wegovy · Health insurance
Covered when: The employer or marketplace plan specifically includes a weight-management drug benefit and prior authorization criteria (BMI, comorbidity) are met.
Not covered when: The plan carries a blanket exclusion for weight-loss medications, which remains common.
Verified: 2026-10-13 · 5 primary sources

Wegovy (semaglutide) is FDA-approved for chronic weight management in adults with obesity or overweight plus a weight-related condition, unlike Ozempic, which is approved for type 2 diabetes. That distinction matters for coverage, because many health plans historically excluded medications prescribed specifically for weight loss.

Employer plans and marketplace plans differ widely on this. Some formularies cover Wegovy with prior authorization requiring a minimum BMI, documentation of a weight-related condition, and proof of prior diet or lifestyle attempts; others exclude GLP-1 weight-loss drugs from the plan entirely, regardless of medical necessity.

Where Wegovy is covered, cost-sharing and prior authorization renewal requirements — often tied to demonstrated weight loss at set intervals — still apply, and coverage can be tightened or dropped at plan renewal as employers manage the drug class's cost.

What people typically pay

With coverage

With coverage, your out-of-pocket cost depends on your plan's cost-sharing — deductibles, copays, and coinsurance apply to most covered services, so amounts vary widely by plan.

Without coverage

Without coverage, you pay the full retail price, which varies and can be substantial for GLP-1 weight-management drugs; check the manufacturer's list price and any savings programs for current figures.

No specific dollar figures were available from the cited sources; costs vary widely by plan and pharmacy.

How to actually get it covered

Check the formulary before the pharmacy does. Log into your plan or call the number on your card and search Wegovy by name: it will show whether the drug is covered, its tier, and whether prior authorization or step therapy applies. If weight-loss drugs are excluded as a class, no prior authorization will override it, and you can skip to the alternatives.
If it's covered with prior authorization, have your prescriber submit the documentation plans typically ask for: your body mass index against the FDA label's criteria (30 or more, or 27 or more with a weight-related condition), the weight-related diagnosis, and a record of diet and lifestyle attempts. Incomplete submissions are the most common reason for an initial denial.
If your plan excludes weight-loss drugs but you have established cardiovascular disease, ask your prescriber whether the cardiovascular indication applies: the FDA has separately approved Wegovy to reduce the risk of major cardiovascular events in adults with heart disease and obesity or overweight, and some plans cover that indication even when they exclude weight loss.
If you're denied, use your appeal rights. Marketplace and most employer plans must offer an internal appeal and then an independent external review; request the denial letter's clinical criteria and have your prescriber answer them point by point, including the renewal criteria if a continuation was denied.
If it stays uncovered, ask the pharmacy about the manufacturer's savings program for commercially insured patients, use an FSA or HSA (a prescribed medicine is a qualified medical expense under IRS Publication 502), and ask your employer's benefits team whether weight-management coverage is being added at the next plan year — the exclusion is a plan-design choice that renews annually.

Common questions

How do I check whether my own health plan covers Wegovy before I fill it?

Look up your plan's drug formulary — usually on the insurer's member portal or the summary of benefits — and search for Wegovy or semaglutide, noting whether it lists a prior-authorization requirement. If it's not listed at all, your plan may carry a weight-loss drug exclusion. You can also call the member services number on your card and ask specifically whether GLP-1 drugs for weight management are a covered benefit under your plan.

What does a Wegovy prior authorization typically ask for?

Plans that cover it commonly require a documented BMI at or above a set threshold and evidence you've tried diet and lifestyle changes, though the exact criteria vary by plan. Your prescriber submits this clinical documentation to the insurer before the pharmacy can fill it. Approvals are often time-limited, so renewals may require showing measurable weight loss to continue.

My plan covers Ozempic but denied Wegovy — how is that possible when it's the same drug?

Ozempic and Wegovy both contain semaglutide, but Ozempic is FDA-approved for type 2 diabetes while Wegovy is approved for weight management. Many plans cover the diabetes indication and exclude weight-loss drugs entirely, so the denial can be about what the drug is prescribed for, not the molecule. Getting a diabetes drug prescribed off-label for weight loss generally won't work around a weight-loss exclusion either.

That's the general answer. Yours is written in your actual policy.

Drop in your policy or benefits document and get the answer for your exact coverage — with the clause it comes from. Nothing is stored.

Check my policy →